Navigation Links
A 300 Million Euro Boost for Biomedicine in Berlin
Date:11/13/2012

BERLIN, November 13, 2012 /PRNewswire/ --

Two of Berlin's largest biomedical research centers are merging to form the Berlin Institute of Health (BHI), a joint venture that will receive at least 300 million euros in new funding over the next five years. This makes Berlin an even more significant and attractive research site, not only in the field of biomedicine. This is happening at the right time, for an aging demographic means that there is an increasing demand for health care products and services. Germany Trade & Invest will have experts at this year's MEDICA, the world's largest health fair, from November 14 to 17 to inform visitors about the industry's latest business opportunities.

"The BHI will make Berlin one of the world's top sites for medical excellence and will attract the world's best scientists and junior doctors. The partnership between the Berlin state and federal government has created an exemplary model of cooperation between university and non-university research. Germany has a globally recognized biomedical sector, and it will only improve due to the Institute's innovative models to train medical talent," said Dr. Sandra Bütow, chemical and health expert at Germany Trade & Invest.

Germany is renowned for its effective public-private partnerships such as the Central Innovation Program SME, a country-wide support measure that provides sustainable support to the innovative capabilities and competiveness of small- and medium-sized enterprises. Participants include businesses and researchers from the health and wellness industry who collaborate in order to find innovative and value-added healthcare solutions.

General Electric has also seized on the market opportunity in Germany due to its infrastructure, research and development and changing demographic. Their objective is to powerfully expand its medical division and establish close partnerships with university hospitals.

Germany Trade & Invest is the foreign trade and inward investment agency of the Federal Republic of Germany. The organization advises foreign companies seeking to expand into the German market. It supports German companies that seek to enter foreign markets, with foreign trade information.

Germany Trade & Invest
Andreas Bilfinger
e-mail: andreas.bilfinger@gtai.com
T: +49(0)30-200099-173
http://www.gtai.com/press-subscription
http://twitter.com/gtai_com
http://youtube.com/gtai


'/>"/>
SOURCE Germany Trade and Invest
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
3. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
4. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
5. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
6. BioPower Systems Awarded $5 Million from Victorian Government
7. InnoPharma Completes $15 Million Series A Financing
8. Aratana Therapeutics Completes $15 Million Series B Financing
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. CeNeRx BioPharma Completes $4.85 Million Financing
11. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... June 22, 2016 Research and Markets has ... report to their offering. ... 2014 from $29.3 billion in 2013. The market is expected to ... from 2015 to 2020, increasing from $50.6 billion in 2015 to ... forecasts during the forecast period (2015 to 2020) are discussed. As ...
(Date:6/22/2016)... 2016   ViaCyte, Inc. , a privately-held regenerative ... replacement therapy for the treatment of diabetes in clinical-stage ... Meeting.  ISSCR 2016, the Global Stem Cell Event, is ... in San Francisco.    ... follows:Event: , Focus Session: Tools for Basic and Applied ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):